Psychedelic Stocks Revive Therapeutics Ltd (OTCMKTS:RVVTF) Appoints Dr. John Fahy To Lead Bucillamine Study In SARS-CoV-2 By Larry Zweig January 05, 2021 Revive Therapeutics Ltd (OTCMKTS:RVVTF) has appointed Dr. John Fahy as a Scientifics and Clinical advisor of the company to help in the expansion and analysis of clinical data on the current FDA phase 3 clinical study. The study i...
